Endometrial carcinoma is the most common neoplasm of the female genital tract, accounting for nearly one half of all gynecologic cancers in the Western world. Although intensive research on pathological phenomena of endometrial cancer is currently going on, but exact cause and biological aspects of this disease are not well described yet. In addition to well-documented roles of gonadotropin-releasing hormone (GnRH) in hypopituitary ovarian (HPO) axis, the agonistic or antagonistic analogs (or both) of GnRH have been shown to inhibit the proliferation of a variety of human gynecologic cancers. Thus, in the present study, we further examined the possibility that GnRH induces integrin beta3 and activation of focal adhesion kinase (FAK) through...
Triple-negative breast cancer does not express estrogen and progesterone receptors, and no overexpre...
It is increasingly apparent that GnRH-II acts as an autocrine/paracrine regulator in non-pituitary t...
Poster Session 14 - Growth Factor, Hormone, and Cytokine Signaling in Invasion: abstract no. 5190Ova...
Background: More than 25% of patients diagnosed with endometrial carcinoma have an ...
In addition to its well-established role as a neuroendocrine regulator at the level of the pituitar...
Ovarian cancer is the most lethal of all gynecological cancers. Most deaths from ovarian cancer are ...
Gonadotrophin releasing hormone analogues (GnRHa) have been used to treat recurrent endometrial canc...
Abstract The expression of GnRH (GnRH-I, LHRH) and its receptor as a part of an autocrine regulatory...
Gonadotropin-releasing hormone (GnRH) receptor is present in 80% of ovarian cancer, and numerous stu...
Several Studies have previously reported the expression of the gonadotropin-releasing hormone recept...
Considering the extrapituitary roles for gonadotropin-releasing hormone (GnRH) in reproductive tiss...
BACKGROUND: We recently demonstrated the effect of gonadotrophin-releasing hormone agonist (GnRHa) o...
Ovarian cancer has a clear predilection to metastasize to the peritoneum, which represents one of th...
The Gonadotropin-Releasing Hormone (GnRH) exists in two isoforms, GnRH-I and GnRH-II, in most verteb...
Gonadotropin-releasing hormone (GnRH) has historically been known as a pituitary hormone; however, i...
Triple-negative breast cancer does not express estrogen and progesterone receptors, and no overexpre...
It is increasingly apparent that GnRH-II acts as an autocrine/paracrine regulator in non-pituitary t...
Poster Session 14 - Growth Factor, Hormone, and Cytokine Signaling in Invasion: abstract no. 5190Ova...
Background: More than 25% of patients diagnosed with endometrial carcinoma have an ...
In addition to its well-established role as a neuroendocrine regulator at the level of the pituitar...
Ovarian cancer is the most lethal of all gynecological cancers. Most deaths from ovarian cancer are ...
Gonadotrophin releasing hormone analogues (GnRHa) have been used to treat recurrent endometrial canc...
Abstract The expression of GnRH (GnRH-I, LHRH) and its receptor as a part of an autocrine regulatory...
Gonadotropin-releasing hormone (GnRH) receptor is present in 80% of ovarian cancer, and numerous stu...
Several Studies have previously reported the expression of the gonadotropin-releasing hormone recept...
Considering the extrapituitary roles for gonadotropin-releasing hormone (GnRH) in reproductive tiss...
BACKGROUND: We recently demonstrated the effect of gonadotrophin-releasing hormone agonist (GnRHa) o...
Ovarian cancer has a clear predilection to metastasize to the peritoneum, which represents one of th...
The Gonadotropin-Releasing Hormone (GnRH) exists in two isoforms, GnRH-I and GnRH-II, in most verteb...
Gonadotropin-releasing hormone (GnRH) has historically been known as a pituitary hormone; however, i...
Triple-negative breast cancer does not express estrogen and progesterone receptors, and no overexpre...
It is increasingly apparent that GnRH-II acts as an autocrine/paracrine regulator in non-pituitary t...
Poster Session 14 - Growth Factor, Hormone, and Cytokine Signaling in Invasion: abstract no. 5190Ova...